Jean Francois Formela, Director, Ten Percent Owner at Horizon Therapeutics, holds 1.14M shares in Korro Bio (Ticker: KRRO), holds 7.29K shares in Intellia Therapeutics (Ticker: NTLA), holds 4.14M shares in Ikena Oncology (Ticker: IKNA).
What was Jean Francois Formela’s latest transaction?
Jean Francois Formela latest transaction was an Uninformative Buy of $999.99K.
What was Jean Francois Formela's most profitable transaction?
Jean Francois Formela’s most profitable transaction was an Informative Sell of NTLA stock on March 22, 2018. The return on the trade was 29.80%.
What is Jean Francois Formela's role in Horizon Therapeutics?
Jean Francois Formela's role in Horizon Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.